세계의 식욕 촉진제 시장 보고서(2025년)
Appetite Stimulant Global Market Report 2025
상품코드 : 1760463
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

식욕 촉진제 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 예측 기간의 성장은 만성 질환에 대한 부담 증가, 고령화 인구 증가, 소아과에서 식욕 촉진제 사용 확대, 영양 보충제에 대한 수요 증가, 신약의 규제 승인에 기인할 수 있습니다. 이 기간에 예상되는 주요 동향에는 약물 제제의 기술적 진보, 단백질 기반 보충제의 혁신, 칸나비노이드 기반 치료법의 개발, 개별화 영양과 정밀의료, 그렐린 수용체 작용제의 연구 개발의 진행 등이 있습니다.

만성질환의 유병률 상승은 향후 수 년간 식욕 촉진제 시장의 성장을 가속할 것으로 예측됩니다. 심혈관 질환 등의 원인이 되는 식생활의 교란과 관련되어 있습니다. 식욕 촉진제는 전반적인 영양 상태를 개선해, 공복감을 높이는 것으로, 환자의 체중 증가나 유지를 도울 수 있어, 만성 질환의 관리에 중요한 역할을 완수합니다. 호주 보건복지연구소는 2024년 6월 만성질환으로 인한 사망률이 2021년 인구 10만 명당 459명에서 2022년 10만 명당 490명으로 증가했다고 밝혔습니다.

식욕 촉진제 시장의 기업은 건강 지향의 소비자를 끌어당기기 위해, 아유르베다 식욕 촉진제 등의 혁신적인 제품에 점점 더 집중하고 있습니다. 아유르베다 식욕 촉진제는 소화를 촉진하고 영양소 흡수를 개선하는 데 도움이 되는 전통 약초에서 추출한 천연 요법으로, 식욕을 증가시킬 수 있습니다. 2024년 10월 인도 기반의 제약 회사인 Lupin Limited는 어린이들에게 건강한 식습관과 영양 인식을 증진하기 위한 캠페인인 Aptivate Achi Bhookh Fest를 시작했습니다. 이 이벤트에는 대화형 활동과 전문가 세션이 포함되어 있으며 학교와 주거 지역에서 250,000 명에게 도달 할 계획입니다. 격려하고 강한 면역력을 촉진하도록 설계된 유아용 아유르베다 식욕 촉진제인 Aptivate를 특징으로 하며, 영양에 대한 자연스럽고 총체적인 영양 접근에 대한 관심의 고조를 강조하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

An appetite stimulant refers to any substance or product designed to increase an individual's appetite, particularly in cases where hunger is lost due to medical conditions, treatments, or other factors. These stimulants work by influencing hormones or brain functions that control hunger signals, thereby promoting the desire to eat.

The main types of appetite stimulants are prescription, over-the-counter, and natural. Prescription appetite stimulants are medications used under medical supervision to help boost hunger in individuals experiencing significant appetite loss due to conditions such as cancer, HIV/AIDS, or chronic illnesses. These stimulants are available in various forms, including liquid formulations, powder formulations, capsules and tablets, and functional foods. They are distributed through different channels, such as hospital pharmacies, online pharmacies, and retail pharmacies, and are used by a wide range of end-users, including hospitals, homecare providers, and specialty centers.

The appetite stimulant market research report is one of a series of new reports from The Business Research Company that provides appetite stimulant market statistics, including the appetite stimulant industry global market size, regional shares, competitors with the appetite stimulant market share, detailed appetite stimulant market segments, market trends, and opportunities, and any further data you may need to thrive in the appetite stimulant industry. This appetite stimulant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The appetite stimulant market size has grown strongly in recent years. It will grow from $1.75 billion in 2024 to $1.92 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to the increased prevalence of cancer and HIV-related cachexia, off-label use of antidepressants for weight gain, a rise in awareness of malnutrition, hospital-based nutrition management, and the use of corticosteroids in chronic illness care.

The appetite stimulant market size is expected to see strong growth in the next few years. It will grow to $2.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the rising burden of chronic diseases, a growing aging population, the expanding use of appetite stimulants in pediatrics, increasing demand for nutritional supplements, and regulatory approvals of new drugs. Major trends expected during this period include technological advancements in drug formulation, innovations in protein-based supplements, the development of cannabinoid-based therapies, personalized nutrition and precision medicine, and ongoing research and development in ghrelin receptor agonists.

The rising prevalence of chronic diseases is expected to fuel the growth of the appetite stimulant market in the coming years. Chronic diseases are long-term medical conditions that typically last for three months or more and often worsen over time. The increasing prevalence of chronic diseases is primarily linked to poor dietary habits, including high consumption of processed foods, sugars, and unhealthy fats, which contribute to obesity, diabetes, cardiovascular diseases, and other conditions. Appetite stimulants play a critical role in managing chronic diseases by improving overall nutritional status and enhancing hunger, which can help patients gain or maintain weight. For example, the Australian Institute of Health and Welfare reported in June 2024 that the rate of deaths attributed to chronic conditions increased from 459 per 100,000 population in 2021 to 490 per 100,000 in 2022. As the demand for nutritional support rises due to these health conditions, the appetite stimulant market continues to expand.

Companies in the appetite stimulant market are increasingly focusing on innovative products, including Ayurvedic appetite stimulants, to attract health-conscious consumers. Ayurvedic appetite stimulants are natural remedies derived from traditional herbs that help enhance digestion, stimulate digestive fire, and improve nutrient absorption, all of which can increase appetite. For example, in October 2024, Lupin Limited, an India-based pharmaceutical company, launched the Aptivate Achi Bhookh Fest, a campaign aimed at promoting healthy eating habits and nutrition awareness among children. The event includes interactive activities and expert-led sessions, with plans to reach 250,000 people across schools and residential areas. The campaign features Aptivate, an Ayurvedic appetite stimulant for children, designed to encourage healthy eating habits and promote strong immunity, highlighting the growing interest in natural and holistic approaches to nutrition.

In January 2025, Zuellig Pharma Corporation, a Singapore-based healthcare distribution and pharmaceutical solutions company, acquired the Propan brand from ADP Pharma Corporation for an undisclosed amount. With this acquisition, Zuellig Pharma aims to enhance its consumer health portfolio by adding a trusted appetite stimulant and multivitamin brand, strengthening its ability to offer high-quality healthcare solutions tailored to the nutritional needs of various age groups. ADP Pharma Corporation, based in the Philippines, specializes in appetite stimulants, and this acquisition enables Zuellig Pharma to expand its presence in the growing appetite stimulant market.

Major players in the appetite stimulant market are Bristol Myers Squibb, Novartis AG, Solvay Pharmaceuticals, Lupin Limited, TIL Healthcare Private Limited, Zeon Lifesciences Limited, Apex Laboratories Private Limited, Nuray Chemicals Private Limited, Arlak Biotech Private Limited, AdvaCare Pharma USA LLC, Dwarkesh Pharmaceuticals Private Limited, Par Pharmaceutical Companies, Inc., Salvus Healthcare Private Limited, Epitome Pharmaceuticals Private Limited, Abiba Pharmacia Private Limited, Pharmika India Private Limited, Wellona Pharma, SiNi Pharma, Vibcare Pharma Private Limited, Mayons Pharmaceuticals Private Limited.

North America was the largest region in the appetite stimulant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in appetite stimulant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the appetite stimulant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The appetite stimulant market consists of sales of cyproheptadine, mirtazapine, and anamorelin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.)

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Appetite Stimulant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on appetite stimulant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for appetite stimulant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The appetite stimulant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Appetite Stimulant Market Characteristics

3. Appetite Stimulant Market Trends And Strategies

4. Appetite Stimulant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Appetite Stimulant Growth Analysis And Strategic Analysis Framework

6. Appetite Stimulant Market Segmentation

7. Appetite Stimulant Market Regional And Country Analysis

8. Asia-Pacific Appetite Stimulant Market

9. China Appetite Stimulant Market

10. India Appetite Stimulant Market

11. Japan Appetite Stimulant Market

12. Australia Appetite Stimulant Market

13. Indonesia Appetite Stimulant Market

14. South Korea Appetite Stimulant Market

15. Western Europe Appetite Stimulant Market

16. UK Appetite Stimulant Market

17. Germany Appetite Stimulant Market

18. France Appetite Stimulant Market

19. Italy Appetite Stimulant Market

20. Spain Appetite Stimulant Market

21. Eastern Europe Appetite Stimulant Market

22. Russia Appetite Stimulant Market

23. North America Appetite Stimulant Market

24. USA Appetite Stimulant Market

25. Canada Appetite Stimulant Market

26. South America Appetite Stimulant Market

27. Brazil Appetite Stimulant Market

28. Middle East Appetite Stimulant Market

29. Africa Appetite Stimulant Market

30. Appetite Stimulant Market Competitive Landscape And Company Profiles

31. Appetite Stimulant Market Other Major And Innovative Companies

32. Global Appetite Stimulant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Appetite Stimulant Market

34. Recent Developments In The Appetite Stimulant Market

35. Appetite Stimulant Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기